92 related articles for article (PubMed ID: 9289961)
1. [A clinical study of the efficacy of and tolerance for the combined transdermal preparation Estracomb TTS (CIBA)].
Tanchev S; Slaveĭkov S
Akush Ginekol (Sofiia); 1997; 36(1):33-5. PubMed ID: 9289961
[TBL] [Abstract][Full Text] [Related]
2. [An efficacy and tolerance study of transdermal estrogen replacement therapy with the preparation Systen R50 (Cilag)].
Tanchev S; Moskova P
Akush Ginekol (Sofiia); 1995; 34(2):65-7. PubMed ID: 8651434
[TBL] [Abstract][Full Text] [Related]
3. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Rozenberg S; Ylikorkala O; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
[TBL] [Abstract][Full Text] [Related]
4. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
Rachev E
Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
[TBL] [Abstract][Full Text] [Related]
5. Transdermal administration of oestrogen/progestagen hormone replacement therapy.
Whitehead MI; Fraser D; Schenkel L; Crook D; Stevenson JC
Lancet; 1990 Feb; 335(8685):310-2. PubMed ID: 1967769
[TBL] [Abstract][Full Text] [Related]
6. Transdermal hormonal replacement therapy with transdermal progestin every second month.
Lindgren R; Risberg B; Hammar M; Berg G
Maturitas; 1995 Jun; 22(1):25-30. PubMed ID: 7666813
[TBL] [Abstract][Full Text] [Related]
7. The effects of continuous combined transdermal oestrogen-progestogen treatment on bleeding patterns and the endometrium in postmenopausal women.
Oosterbaan HP; van Buuren AH; Schram JH; van Kempen PJ; Ubachs JM; van Leusden HA; Beyer GP
Maturitas; 1995 Apr; 21(3):211-9. PubMed ID: 7616870
[TBL] [Abstract][Full Text] [Related]
8. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
Perrone G; Falaschi P; Capri O; Pastore R; Galoppi P; D'Urso R; Martocchia A; Anelli G; Zichella L
Int J Fertil Menopausal Stud; 1994; 39(4):202-7. PubMed ID: 7951402
[TBL] [Abstract][Full Text] [Related]
9. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Johannisson E; Holinka CF; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
[TBL] [Abstract][Full Text] [Related]
10. [Transdermal administration of estrogens in women with the postcastration and climacteric syndromes].
Rotta L; Matĕchová E
Cesk Gynekol; 1992 Sep; 57(7):336-40. PubMed ID: 1394497
[TBL] [Abstract][Full Text] [Related]
11. Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women.
Wiseman LR; McTavish D
Drugs Aging; 1994 Mar; 4(3):238-56. PubMed ID: 8199397
[TBL] [Abstract][Full Text] [Related]
12. [Influence of hormone replacement therapy on the quality of life in postmenopausal women with hypertension].
Czarnecka D; Klocek M; Betkowska-Korpała B; Jankowski P; Olszanecka A; Kawecka-Jaszcz K
Przegl Lek; 2000; 57(7-8):397-401. PubMed ID: 11109313
[TBL] [Abstract][Full Text] [Related]
13. [Kliogest--the possibility of hormonal substitution in the postmenopause].
Rachev E
Akush Ginekol (Sofiia); 1993; 32(3):64-6. PubMed ID: 8037328
[TBL] [Abstract][Full Text] [Related]
14. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms.
Adler G; Young D; Galant R; Quinn L; Witchger MS; Maki KC
Gynecol Obstet Invest; 2005; 59(4):212-9. PubMed ID: 15753617
[TBL] [Abstract][Full Text] [Related]
16. [Activelle - modern low-dose hormone replacement therapy for postmenopausal women].
Novo Nordisk.
Akush Ginekol (Sofiia); 2000; 39 Suppl 2():28-30. PubMed ID: 11188014
[No Abstract] [Full Text] [Related]
17. Hormonal therapy with patch or pill: how much does it matter?
Schaudig K; Thomssen C
Thromb Haemost; 2007 Apr; 97(4):503-4. PubMed ID: 17393010
[No Abstract] [Full Text] [Related]
18. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
Kurtay G; Ozmen B; Erguder I
Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
[TBL] [Abstract][Full Text] [Related]
19. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
Taşçı T; Şükür YE; Özmen B; Atabekoğlu CS; Cengiz SD; Koçbulut E; Berker B; Sönmezer M
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():50-4. PubMed ID: 24655552
[TBL] [Abstract][Full Text] [Related]
20. Spacing-out of progestin--efficacy, tolerability and compliance of two regimens for hormonal replacement in the late postmenopause.
Rabe T; Mueck AO; Deuringer FU; Vladescú E; Runnebaum B
Gynecol Endocrinol; 1997 Dec; 11(6):383-92. PubMed ID: 9476087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
